Latest Lead News

Impact Minerals has entered a joint venture with Kuniko Limited to advance the Commonwealth gold-silver-copper project in New South Wales, retaining a 30% free carried interest while focusing on its Lake Hope High Purity Alumina project.

Kuniko Limited has executed a binding earn-in and joint venture agreement to acquire up to 70% of the Commonwealth Gold-Silver Project in NSW, backed by a rights issue to fund exploration and drilling. The project offers significant resource potential in a Tier-1 jurisdiction with existing inferred mineral resources.

The ACCC has raised preliminary concerns that IAG’s proposed acquisition of RAC Insurance in Western Australia could reduce competition, potentially leading to higher premiums and limited repair service access for rivals.

FMR Resources has raised $3.4 million through a strategic equity placement to accelerate exploration at its Southern Porphyry target in Chile, aiming to unlock significant copper and gold potential.

Superior Resources has expanded its Greenvale Project by over half, becoming the largest landholder in northeast Queensland’s promising mineral region. This strategic move positions the company at the forefront of multiple world-class mineral opportunities.

Savana Asset Management signals a strategic shift favoring US small caps amid easing Federal Reserve rates and cooling enthusiasm for mega-cap tech stocks. Kohl’s standout earnings further boost the fund’s outlook.

Green360 Technologies announces CEO Bojan Bogunovic's resignation effective October 31, with Executive Chairman Aaron Banks stepping in to lead daily operations during a pivotal growth phase.

Novo Resources has initiated its first reverse circulation drilling at the Sherlock Crossing gold-antimony prospect, while advancing exploration at its Wyloo polymetallic project and NSW gold assets, signaling a busy second half of 2025.

Core Lithium has launched a $10 million Share Purchase Plan offering eligible shareholders the chance to buy new shares at the same price as a recent institutional placement, aiming to bolster working capital and support key project developments.

Iress Limited has appointed Andrew Russell as its new Group CEO, marking a strategic leadership shift following a major company transformation. Russell’s extensive fintech experience positions him to lead Iress into a product and client-focused future.

Amplia Therapeutics has commenced dosing the first patient in its new pancreatic cancer trial combining narmafotinib with FOLFIRINOX chemotherapy, marking a key milestone in its drug development journey.

Select Harvests has confirmed the presence of varroa mite in its South Australian orchard but reports no immediate impact on the 2026 almond crop. The company is working closely with authorities to contain the issue and is adjusting its bee sourcing strategy for future seasons.